Prediction of in vivo Bioavailibility by in vitro Characterization of Ethylenediamine Dipropanoic Acid Derivatives with Cytotoxic Activity

Authors

  • Biljana Tubić Agency for Medicines and Medical devices of Bosnia and Herzegovina and Faculty of Medicine - Department of Pharmacy, University of Banja Luka
  • Sandra Vladimorov Faculty of Pharmacy, University of Belgrade
  • Bojan Markovic Faculty of Pharmacy, University of Belgrade
  • Tibor Sabo Faculty of Chemistry, University of Belgrade

DOI:

https://doi.org/10.17344/acsi.2017.3477

Keywords:

transfer of the UHPLC-MS/MS, cross validation, (S, S)-ethylenediamine-N, N’-di-2-(3-cyclohexyl) propanoic acid esters, membrane permeability, lipophilicity

Abstract

O,O’-diethyl-(S,S)-ethylenediamine-N,N’-di-2-(3-cyclohexyl)propanoate (DE-EDCP) is novel substance with cytotoxic activity in human leukemic cells. The aim of this study has been to predict in vivo bioavailability of the DE-EDCP and its potential metabolite (S,S)-ethylenediamine-N,N’-di-2-(3-cyclohexyl)propanoic acid (EDCP) by in vitro characterization which includes determination of lipophilicity and passive membrane permeability. There has also been evaluated inter-laboratory reproducibility of the bio-analytical method which was previously developed and validated for non-clinical study of the DE-EDCP and EDCP.
Distribution coefficient n-octanol/water was 1.68 and 0.03, and apparent permeability coefficient was 4 × 10–4 cm/s and 20 × 10–4 cm/s, for the DE-EDCP and EDCP, respectively.
Observed results have shown that the DE-EDCP is more lipophilic with better membrane retention, but the EDCP has better pass through the membrane. Also, there has been demonstrated a reproducibility and robustness of the proposed bio-analytical method.

Downloads

Published

20.03.2018

Issue

Section

Biomedical applications